Publications by authors named "Errani C"

Purpose: Periosteal chondrosarcoma (PCS) is the rarest subtype of chondrosarcoma and is recognized as a low-grade malignant tumour, reported to have an 88% ten year overall survival rate. The relationship between surgical margins and clinical outcome is inconsistent; some authors claim that PCS can be successfully treated with marginal resection and others report more local recurrence and distant metastasis with marginal compared to wide resection. This study was intended to report the treatment and prognosis of localized PCS patients from the Japanese National Bone and Soft Tissue Tumor Registry database and to perform a systematic review of the literature to determine the relationship between surgical margins and rates of local recurrence, distant metastasis, and mortality.

View Article and Find Full Text PDF

Introduction: Mesenchymal chondrosarcoma (MCS) is a malignant, biphasic, high-grade, primitive mesenchymal tumor that has a well-differentiated, organized hyaline component. MCS has a poor prognosis, and treatment recommended for localized MCS is based on wide resection while controversy remains regarding the efficacy of adjuvant chemotherapy and radiotherapy. In this study, we aimed to investigate the prognostic factors of MCS, especially the efficacy of adjuvant chemotherapy and radiotherapy for localized MCS.

View Article and Find Full Text PDF

Introduction: Limb salvage surgery in children following bone sarcoma resection is a challenging problem because of the small size of the bones, the lack of appropriate size-matched implants, and the risk of limb-length discrepancy once skeletal growth is complete, secondary to the loss of the epiphyseal plate. Although several reconstruction options are available in children with bone sarcomas, such as vascularized fibula, massive bone allograft, extracorporeal devitalized autograft, endoprosthesis, and allograft-prosthesis composite, a consensus has not been reached on the best reconstruction method. The purpose of the present study is to propose an algorithm for reconstruction after resection of bone sarcomas in children.

View Article and Find Full Text PDF
Article Synopsis
  • The study looks at surgeries done on kids' hips after removing bone tumors, focusing on two methods: modular prostheses and allograft-prosthesis composites.
  • Researchers wanted to find out how often kids needed more surgery and what kinds of problems happened after these two types of surgeries.
  • Over 54 kids were treated from 2000 to 2021, with different methods used depending on their age and how well they responded to treatment.
View Article and Find Full Text PDF

Introduction: To prevent infection after limb-sparing surgery for primary malignant bone tumors, it is important to cover the megaprosthesis with muscle tissue that has sufficient blood flow. Coverage with a lateral gastrocnemius flap has been reported in cases of distal femoral replacement in which the vastus lateralis and vastus intermedius muscles have been resected; however, the risk of peroneal nerve palsy is reportedly high because the muscle flap passes near the peroneal head. This study was performed to examine the postoperative outcomes of patients with primary malignant bone tumors of the distal femur who underwent wide resection (including the vastus lateralis and vastus intermedius muscles) followed by reconstruction with a megaprosthesis and coverage of the lateral side of the prosthesis with a sartorius muscle flap.

View Article and Find Full Text PDF

Purpose: Immune checkpoint inhibitors (ICIs) have improved the prognosis of patients with cancer, such as melanoma, renal cell carcinoma, head and neck cancer, non-small cell lung cancer (NSCLC), and urothelial carcinoma. The extension of life expectancy has led to an increased incidence of bone metastases (BM) among patients with cancer. BM result in skeletal-related events, including severe pain, pathological fractures, and nerve palsy.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to find a cutoff for predicting histological response in Ewing sarcoma based on tumor volume changes after chemotherapy.
  • Out of 184 patients analyzed, a reduction of over 65% in tumor volume was identified as an optimal threshold for a good histological response, with a 45% response rate of necrosis.
  • While tumor volume reduction itself did not influence survival, poor histological responses were linked to decreased relapse-free survival, indicating potential benefits from more aggressive treatments for at-risk patients.
View Article and Find Full Text PDF

Purpose: Dedifferentiated low-grade osteosarcomas, which are considered high grade malignancies, can arise from the dedifferentiation of parosteal and low-grade osteosarcomas. Usually, localized dedifferentiated low-grade osteosarcomas are treated by wide resection, and the efficacy of adjuvant chemotherapy is controversial. We conducted a systematic review of studies that investigated the rates of mortality and significant events, such as recurrence and metastases, in localized dedifferentiated low-grade osteosarcoma patients who received wide resection only and in those who received wide resection and (neo-)adjuvant chemotherapy.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the histological and imaging characteristics of myoepithelial carcinoma in bone and soft tissue, examining data from 22 patients over time.
  • Results showed that a significant number of patients experienced local recurrence (36.3%) and distant metastasis (50.0%), with severe cytological changes and vascular invasion being noted in many cases.
  • The findings suggest that understanding these histological and imaging features could help identify the aggressive nature of myoepithelial carcinoma, highlighting its high risk for recurrence and metastasis.
View Article and Find Full Text PDF
Article Synopsis
  • Curettage is the recommended treatment for early-stage giant cell tumors of bone (GCTB) without prior denosumab, especially in various skeletal sites, and involves using bone chips and plate fixation for distal femur cases to minimize complications.
  • For stage 3 aggressive GCTB, en bloc resection combined with preoperative denosumab is suggested, while denosumab is the standard treatment for inoperable and metastatic cases, with zoledronic acid being a cost-effective alternative.
  • Surgery remains the primary treatment for malignant GCTB, and careful monitoring for potential malignant transformation is necessary if tumor growth occurs.
View Article and Find Full Text PDF

Background: Several reconstruction methods exist for Malawer type I/V proximal humerus reconstruction after bone tumor resection; however, no consensus has been reached regarding the preferred methods.

Methods: We conducted a literature search on various types of proximal humerus oncologic reconstruction methods. We collected data on postoperative functional outcomes assessed based on Musculoskeletal Tumor Society (MSTS) scores, 5-year reconstruction survival rates, and complications.

View Article and Find Full Text PDF

Purpose: The patients with femoral metastasis in the inter- or subtrochanteric area could be treated with intramedullary nailing or prosthetic reconstruction, however, it is controversial which surgical treatment could offer less complications and implant failure. Our purpose was to define the risk of complications and implant survival in patients treated with intramedullary nailing or prosthetic reconstruction.

Methods: We analyzed studies reporting the risk of complications, reoperations and removal of the implant in patients treated with intramedullary nailing, hemiarthroplasty, arthroplasty or megaprosthesis.

View Article and Find Full Text PDF

Biopsy is a pivotal component in the diagnostic process of bone and soft tissue tumors. The objective is to obtain adequate tissue without compromising local tumor dissemination and the patient's survival. This review explores contemporary principles and practices in musculoskeletal biopsies, emphasizing the critical role of diagnostic accuracy while also delving into the evolving landscape of liquid biopsies as a promising alternative in the field.

View Article and Find Full Text PDF

Purpose: There is a lack of consensus regarding the best type of reconstruction of the proximal femur following bone tumor resection. The objective of this study was to analyze the complication risks, implant survival, and functional outcomes following modular prosthesis (MP) and allograft-prosthesis composite (APC) reconstruction of the proximal femur after primary bone tumor resections.

Methods: We performed a search in the PubMed and Scopus libraries, obtaining 1 843 studies.

View Article and Find Full Text PDF

Dedifferentiated chondrosarcoma (DDCS) is a high-grade subtype of chondrosarcoma with the bimorphic histological appearance of a conventional chondrosarcoma component with abrupt transition to a high-grade, non-cartilaginous sarcoma. DDCS can be radiographically divided into central and peripheral types. Wide resection is currently the main therapeutic option for localized DDCS.

View Article and Find Full Text PDF
Article Synopsis
  • Reconstruction of the proximal humerus in children who have bone tumors is challenging due to small bone size and potential limb length discrepancies after surgery.
  • There are various reconstruction methods available, including resurfaced allograft-prosthesis composites, but a definitive best option has not been established.
  • This study investigates complications and patient outcomes for 18 children who received resurfaced allograft-prosthesis composites after tumor resection, aiming to assess the success of this surgical technique.
View Article and Find Full Text PDF

Aims: Low-grade central osteosarcoma (LGCOS), a rare type of osteosarcoma, often has misleading radiological and pathological features that overlap with those of other bone tumours, thereby complicating diagnosis and treatment. We aimed to analyze the clinical, radiological, and pathological features of patients with LGCOS, with a focus on diagnosis, treatment, and outcomes.

Methods: We retrospectively analyzed the medical records of 49 patients with LGCOS (Broder's grade 1 to 2) treated between January 1985 and December 2017 in a single institute.

View Article and Find Full Text PDF
Article Synopsis
  • This study compared outcomes of patients with localized myxoid liposarcoma treated with surgery plus adjuvant chemotherapy versus surgery alone, using a dataset of 456 patients over an 18-year period.
  • Analysis revealed no significant differences in local recurrence, distant metastasis, or disease-specific survival rates between the two treatment groups in the overall cohort or specifically in high-risk patients.
  • The findings suggest that adjuvant chemotherapy has a limited impact on improving patient outcomes for localized myxoid liposarcoma.
View Article and Find Full Text PDF

Background And Objective: The prognosis of metastatic renal cell carcinoma (RCC) has markedly improved with the advent of molecular targeted therapies and immune checkpoint inhibitors. However, the therapeutic response in patients with bone metastasis remains low; therefore, surgery still plays a significant role in treatment of bone metastasis. It is important to maintain quality of life for patients with bone metastasis from RCC and avoid reoperation after surgery for bone metastasis.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the treatment outcomes and factors influencing myoepithelial carcinoma of soft tissue and bone based on 33 patients treated between 1998 and 2015.
  • The research found that a significant number of patients experienced local recurrences and metastases, with a five-year survival rate of 62.6% for those with localized tumors.
  • The authors emphasize the need for multidisciplinary treatment approaches, as current chemotherapy options do not significantly improve outcomes for patients with metastatic disease.
View Article and Find Full Text PDF
Article Synopsis
  • Myxoid liposarcoma is more sensitive to radiation than other sarcomas, and this study aimed to compare local recurrence rates, survival, and wound complications between pre-operative and post-operative radiotherapy.
  • The research used data from 200 patients and found that local recurrence rates, disease-specific survival, and wound complication rates were similar for both pre- and post-operative radiotherapy groups.
  • The study concludes that pre-operative radiotherapy offers clinical results comparable to post-operative radiotherapy for localized myxoid liposarcoma.
View Article and Find Full Text PDF

Purpose: Bone marrow adipocytes (BMAs) are the most plentiful cells in the bone marrow and function as an endocrine organ by producing fatty acids, cytokines, and adipokines. Consequently, BMAs can interact with tumor cells, influencing both tumor growth and the onset and progression of bone metastasis. This review aims to systematically evaluate the role of BMAs in the development and progression of bone metastasis.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the clinical behavior and biology of epithelioid haemangioma (EH) of bone, analyzing 42 patients treated between 1978 and 2021.
  • Multifocality was found in 40% of patients, with treatment options ranging from curettage to radiotherapy.
  • The research reveals that multifocal lesions are likely clones of a single neoplastic cell rather than independent tumors, suggesting passive spreading of benign tumor cells rather than aggressive behavior.
View Article and Find Full Text PDF

Background: Osteosarcoma is a highly aggressive malignant bone tumor that affects mainly adolescents and young adults. We analyzed serum biomarkers for their prognostic significance in children with osteosarcoma.

Methods: In this retrospective study, we investigated the prognostic factors in 210 children who were treated for appendicular osteosarcoma, including patient age and sex, tumor site and size (≥8 cm or <8 cm), presence of metastasis, chemotherapy-induced tumor necrosis, serum levels of alkaline phosphatase (AP), C-reactive protein, serum hemoglobin, lactate dehydrogenase, erythrocyte sedimentation rate (ESR), leukocyte counts, platelet count, and neutrophil-lymphocyte ratio.

View Article and Find Full Text PDF